Search

Ben S. Michelson

Examiner (ID: 19370, Phone: (571)270-1164 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1625
Total Applications
286
Issued Applications
177
Pending Applications
1
Abandoned Applications
111

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8063039 [patent_doc_number] => 20110245503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'ENANTIOSELECTIVE SYNTHESIS OF ASYMMETRIC BETA-CARBOLINE INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 13/131751 [patent_app_country] => US [patent_app_date] => 2009-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4114 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245503.pdf [firstpage_image] =>[orig_patent_app_number] => 13131751 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/131751
ENANTIOSELECTIVE SYNTHESIS OF ASYMMETRIC BETA-CARBOLINE INTERMEDIATES Nov 26, 2009 Abandoned
Array ( [id] => 8470079 [patent_doc_number] => 08299258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Method of making piperidine derivatives' [patent_app_type] => utility [patent_app_number] => 12/612089 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3933 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12612089 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/612089
Method of making piperidine derivatives Nov 3, 2009 Issued
Array ( [id] => 6616186 [patent_doc_number] => 20100099701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'ISOQUINOLINONE MODULATORS OF 5-HT3 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/581698 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10406 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099701.pdf [firstpage_image] =>[orig_patent_app_number] => 12581698 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/581698
ISOQUINOLINONE MODULATORS OF 5-HT3 RECEPTORS Oct 18, 2009 Abandoned
Array ( [id] => 9831685 [patent_doc_number] => 08940499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Reagent for blood analysis and method of use thereof' [patent_app_type] => utility [patent_app_number] => 12/580474 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 3624 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12580474 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/580474
Reagent for blood analysis and method of use thereof Oct 15, 2009 Issued
Array ( [id] => 6640003 [patent_doc_number] => 20100174089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'HETEROARYL ARYL ETHERS' [patent_app_type] => utility [patent_app_number] => 12/579568 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3958 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20100174089.pdf [firstpage_image] =>[orig_patent_app_number] => 12579568 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/579568
HETEROARYL ARYL ETHERS Oct 14, 2009 Abandoned
Array ( [id] => 6113632 [patent_doc_number] => 20110190330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'SPIROCYCLIC GPR40 MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/119951 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97374 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190330.pdf [firstpage_image] =>[orig_patent_app_number] => 13119951 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/119951
Spirocyclic GPR40 modulators Oct 12, 2009 Issued
Array ( [id] => 9620973 [patent_doc_number] => 08791147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Calcium receptor modulating agents' [patent_app_type] => utility [patent_app_number] => 13/123468 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16912 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13123468 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/123468
Calcium receptor modulating agents Oct 6, 2009 Issued
Array ( [id] => 6258535 [patent_doc_number] => 20100029939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'PREPARATION OF KETONE AMIDES' [patent_app_type] => utility [patent_app_number] => 12/564504 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2553 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029939.pdf [firstpage_image] =>[orig_patent_app_number] => 12564504 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/564504
PREPARATION OF KETONE AMIDES Sep 21, 2009 Abandoned
Array ( [id] => 9059987 [patent_doc_number] => 08546422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Azaindole derivatives as CRTH2 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/120067 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11220 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120067 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/120067
Azaindole derivatives as CRTH2 receptor antagonists Sep 16, 2009 Issued
Array ( [id] => 6090767 [patent_doc_number] => 20110218217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'PIPERIDYLPROPIONAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS INCLUDING DEPRESSION AND PANIC DISORDER' [patent_app_type] => utility [patent_app_number] => 13/061353 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5219 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218217.pdf [firstpage_image] =>[orig_patent_app_number] => 13061353 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/061353
PIPERIDYLPROPIONAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS INCLUDING DEPRESSION AND PANIC DISORDER Aug 24, 2009 Abandoned
Array ( [id] => 6048727 [patent_doc_number] => 20110207773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'NOVEL PHENYL-QUINOLINE-CARBOXYLIC ACID PYRIDINE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/059799 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6507 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207773.pdf [firstpage_image] =>[orig_patent_app_number] => 13059799 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/059799
NOVEL PHENYL-QUINOLINE-CARBOXYLIC ACID PYRIDINE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS Aug 19, 2009 Abandoned
Array ( [id] => 6167367 [patent_doc_number] => 20110195939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'ANTITUMOR PROPERTIES OF NO MODIFIED PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/056696 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8578 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195939.pdf [firstpage_image] =>[orig_patent_app_number] => 13056696 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/056696
Antitumor properties of NO modified protease inhibitors Jul 29, 2009 Issued
Array ( [id] => 6016876 [patent_doc_number] => 20110224242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 13/055703 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10173 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224242.pdf [firstpage_image] =>[orig_patent_app_number] => 13055703 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/055703
STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES Jul 22, 2009 Abandoned
Array ( [id] => 7574078 [patent_doc_number] => 20110269734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'PIPERIDINYL GPCR AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/003546 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24172 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269734.pdf [firstpage_image] =>[orig_patent_app_number] => 13003546 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/003546
PIPERIDINYL GPCR AGONISTS Jul 9, 2009 Abandoned
Array ( [id] => 7657497 [patent_doc_number] => 20110306766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Process for the Synthesis of N-Demethylated Morphinane Compounds' [patent_app_type] => utility [patent_app_number] => 12/999007 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7261 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306766.pdf [firstpage_image] =>[orig_patent_app_number] => 12999007 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/999007
Process for the Synthesis of N-Demethylated Morphinane Compounds Jun 18, 2009 Abandoned
Array ( [id] => 6151225 [patent_doc_number] => 20110155238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'PYRIDINE TYPE METAL COMPLEX, PHOTOELECTRODE COMPRISING THE METAL COMPLEX, AND DYE-SENSITIZED SOLAR CELL COMPRISING THE PHOTOELECTRODE' [patent_app_type] => utility [patent_app_number] => 12/989515 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8315 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20110155238.pdf [firstpage_image] =>[orig_patent_app_number] => 12989515 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989515
PYRIDINE TYPE METAL COMPLEX, PHOTOELECTRODE COMPRISING THE METAL COMPLEX, AND DYE-SENSITIZED SOLAR CELL COMPRISING THE PHOTOELECTRODE Apr 22, 2009 Abandoned
Array ( [id] => 6071279 [patent_doc_number] => 20110046130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'TETRAHYDRONAPHTHYRIDINES AND AZA DERIVATIVES THEREOF AS HISTAMINE H3 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/935293 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35182 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046130.pdf [firstpage_image] =>[orig_patent_app_number] => 12935293 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/935293
TETRAHYDRONAPHTHYRIDINES AND AZA DERIVATIVES THEREOF AS HISTAMINE H3 RECEPTOR ANTAGONISTS Mar 26, 2009 Abandoned
Array ( [id] => 5343360 [patent_doc_number] => 20090182010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/412194 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35602 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182010.pdf [firstpage_image] =>[orig_patent_app_number] => 12412194 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/412194
COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Mar 25, 2009 Abandoned
Array ( [id] => 8172251 [patent_doc_number] => 20120107854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'REAGENT FOR MEASUREMENT OF CHOLINESTERASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/255051 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4652 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107854.pdf [firstpage_image] =>[orig_patent_app_number] => 13255051 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/255051
REAGENT FOR MEASUREMENT OF CHOLINESTERASE ACTIVITY Mar 2, 2009 Abandoned
Array ( [id] => 6390086 [patent_doc_number] => 20100317865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'ENZYME AND RECEPTOR MODULATION' [patent_app_type] => utility [patent_app_number] => 12/867455 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18089 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317865.pdf [firstpage_image] =>[orig_patent_app_number] => 12867455 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/867455
ENZYME AND RECEPTOR MODULATION Feb 26, 2009 Abandoned
Menu